Novo Nordisk A/S is partnering with telehealth companies including Hims & Hers Health Inc., LifeMD Inc., and Ro to offer ...

Ro today announced an integration with NovoCare® Pharmacy to provide seamless access to all doses of Wegovy® at the best available cash price of $499 per month. By working directly with Novo Nordisk's ...

Novo Nordisk said on Tuesday it was partnering with telehealth firms Hims & Hers, Ro and LifeMD to sell branded versions of ...

Novo Nordisk announced it is expanding patient access to Wegovy® (semaglutide) injection 2.4 mg by enabling select telehealth ...

The 25,000-square-foot-Polaris lounge is in Terminal 1 at United's home hub, Chicago O'Hare International Airport. It has seating for 350 passengers, six additional bathrooms, a second ...

The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...

Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy along with other services to treat obesity. Consumers will now be able to access ...

Novo is expanding its direct-to-consumer efforts around its obesity drug Wegovy, partnering with telehealth companies ...

Customers will get access to the offerings of all dose strengths of Wegovy and a membership at a price starting at $599 per ...

Novo Nordisk and Hims & Hers Health, Inc. today announced a long-term collaboration designed to make proven obesity care and treatments more accessible, more affordable, and more connected for ...

Investing.com -- Shares of Hims & Hers Health, Inc. (NYSE: HIMS) climbed 30% following the announcement of a long-term collaboration with Novo Nordisk (NYSE: NVO) to enhance obesity care. The ...